TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

LORD, ABBETT & CO. LLC's Holding History (CIK: 0000728100)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 13,452,000 Value ($000) $19 Avg Close — Range —
Q3 2025
Shares 12,183,000 Value ($000) $14 Avg Close — Range —
Q2 2025
Shares 9,386,000 Value ($000) $9 Avg Close — Range —
Q1 2025
Shares 9,666,000 Value ($000) $10 Avg Close — Range —